GR860329B - Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof - Google Patents

Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof

Info

Publication number
GR860329B
GR860329B GR860329A GR860100329A GR860329B GR 860329 B GR860329 B GR 860329B GR 860329 A GR860329 A GR 860329A GR 860100329 A GR860100329 A GR 860100329A GR 860329 B GR860329 B GR 860329B
Authority
GR
Greece
Prior art keywords
reagent
bacteric
toxines
hemaglutination
dosage
Prior art date
Application number
GR860329A
Other languages
English (en)
Inventor
Edgard Hans Relyveld
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of GR860329B publication Critical patent/GR860329B/el

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555Red blood cell
    • G01N33/556Fixed or stabilised red blood cell
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/967Standards, controls, materials, e.g. validation studies, buffer systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR860329A 1985-02-05 1986-02-04 Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof GR860329B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8501579A FR2577048B1 (fr) 1985-02-05 1985-02-05 Reactif pour le dosage par hemagglutination des anticorps contre les toxines bacteriennes, procede de preparation et son application

Publications (1)

Publication Number Publication Date
GR860329B true GR860329B (en) 1986-06-05

Family

ID=9315942

Family Applications (1)

Application Number Title Priority Date Filing Date
GR860329A GR860329B (en) 1985-02-05 1986-02-04 Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof

Country Status (11)

Country Link
US (1) US5318913A (el)
EP (1) EP0193439B1 (el)
JP (1) JPS61228356A (el)
AT (1) ATE68601T1 (el)
CA (1) CA1275043A (el)
DE (1) DE3681940D1 (el)
DK (1) DK56386A (el)
ES (2) ES8800757A1 (el)
FR (1) FR2577048B1 (el)
GR (1) GR860329B (el)
PT (1) PT81970B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998031816A1 (en) * 1997-01-17 1998-07-23 Regents Of The University Of Minnesota Dna molecules and protein displaying improved triazine compound degrading ability
US6355271B1 (en) * 1999-02-03 2002-03-12 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
WO2001055409A2 (en) * 2000-01-25 2001-08-02 Regents Of The University Of Minnesota Microbes and methods for remediation
JP2002063917A (ja) * 2000-08-18 2002-02-28 Sony Corp 電気化学デバイス及びその使用方法
FR2821431B1 (fr) * 2001-02-28 2003-11-21 Louis Lery Reactif destine au depistage ante-morten d'atnc
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
US20090041812A1 (en) * 2004-11-01 2009-02-12 Bell Steve J D Therapeutic Calcium Phosphate Particles in Use for Aesthetic of Cosmetic Medicine, and Methods of Manufacture and Use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310964A1 (de) * 1973-03-02 1974-09-05 Schering Ag Antigen- bzw. antigen-proteinkonjugatbeschichtete erythrocytenpraeparation
FR2334107A1 (fr) * 1975-12-05 1977-07-01 Pasteur Institut Procede de couplage de substances biologiques par des liaisons covalentes
FR2403559A1 (fr) * 1977-09-19 1979-04-13 Merieux Inst Nouveau reactif biologique, sa preparation et son application
DE2836046A1 (de) * 1978-08-17 1980-02-28 Behringwerke Ag Immunologisches bestimmungsverfahren
FR2478470A1 (fr) * 1980-03-24 1981-09-25 Pasteur Institut Preparations cellulaires applicables en therapeutique humaine, procede d'obtention et applications
JPS578090A (en) * 1980-06-12 1982-01-16 Shinsei Industries Co Stapler
US4403037A (en) * 1980-10-10 1983-09-06 American Hoechst Corporation Erythrocyte preparations and use thereof in hemagglutination tests
DE3206729A1 (de) * 1982-02-25 1983-09-01 Behringwerke Ag, 3550 Marburg Immunologisches agglutinationsverfahren
JPS5931453A (ja) * 1982-07-14 1984-02-20 Fujirebio Inc 梅毒抗体の測定方法

Also Published As

Publication number Publication date
DK56386D0 (da) 1986-02-05
FR2577048A1 (fr) 1986-08-08
ES557404A0 (es) 1988-11-16
US5318913A (en) 1994-06-07
PT81970B (pt) 1988-01-22
DE3681940D1 (de) 1991-11-21
ATE68601T1 (de) 1991-11-15
ES551659A0 (es) 1987-11-16
JPS61228356A (ja) 1986-10-11
FR2577048B1 (fr) 1988-05-06
DK56386A (da) 1986-08-06
ES8900068A1 (es) 1988-11-16
EP0193439B1 (fr) 1991-10-16
ES8800757A1 (es) 1987-11-16
EP0193439A1 (fr) 1986-09-03
CA1275043A (en) 1990-10-09
PT81970A (fr) 1986-03-01

Similar Documents

Publication Publication Date Title
ES8603271A1 (es) Un metodo de producir una composicion de interleuquina-2
AU1141288A (en) Production of proteins in active forms
DK168790D0 (el)
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
ES8705229A1 (es) Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales
AU589970B2 (en) Animal litter and process for the production thereof
GR3006840T3 (el)
EP0315118A3 (en) Dna coding for endothelin and use thereof
IL86443A0 (en) Protein absorption enhancing agents
AU5508586A (en) Use of efomycins as performance promoters in animals, efomycins and their preparation
BG60542B2 (en) Water soluble composition having coccidiostatic effect
DE3468324D1 (en) Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
AU5581186A (en) Protein absorption enhancing agent
ES8206973A1 (es) Procedimiento de preparar soluciones desagregadas de poli- peptidos
SU1387399A1 (ru) Питательная среда для культивирования лептоспир
SU1445159A1 (ru) Способ поверхностного модифицирования резины
GT198500045A (es) Una composicion para la higiene oral
IE860590L (en) T-pa composition and method of getting into blood 21 -¹dipropionate
IT8349398A0 (it) Pepsina immobilizzata per l'impiego nella eliminazione di immunocomplessi dal sangue e procedimento per eliminare immunocomplessi dal sangue impiegando la pepsina immobilizzata